Iteos Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

iTeos Therapeutics

12/08/2021 15:07

* Iteos Therapeutics Inc  ITOS.OQ  reported a quarterly adjusted
loss of 75 cents​​ per share for the quarter ended in June. The
mean expectation of five analysts for the quarter was for a loss
of 41 cents per share.
* Reported revenue was zero​;  analysts expected $3.91 million. 
* Iteos Therapeutics Inc's reported EPS for the quarter was a
loss of 75 cents​.
* The mean earnings estimate of analysts had risen by
about 18.5% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Iteos Therapeutics Inc shares had fallen by 2.5% this
quarter and lost 26.0% so far this year.
* The company reported a quarterly loss of $26.46 million.
* Wall Street's median 12-month price target for Iteos
Therapeutics Inc is $50.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 02:07 p.m.  ​All
figures in US dollars unless otherwise stated